106
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Cancer and SARS-CoV-2 Infection: A Third-Level Hospital Experience

ORCID Icon, , , , , , , , , , , & ORCID Icon show all
Pages 317-324 | Published online: 20 May 2021

References

  • Liu J, Zhang S, Wu Z, et al. Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study. Ann Intensive Care. 2020;10(1):99. doi:10.1186/s13613-020-00706-3.32737627
  • Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032.32109013
  • Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA. 2020;323(20):e206775. doi:10.1001/jama.2020.6775.
  • Myers LC, Parodi SM, Escobar GJ, Liu VX. Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California. JAMA. 2020;323(21):e207202. doi:10.1001/jama.2020.7202.
  • Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422. doi:10.1016/S2213-2600(20)30076-X.32085846
  • Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–337. doi:10.1016/S1470-2045(20)30096-6.32066541
  • Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 transmission in patients with cancer at a Tertiary Care Hospital in Wuhan, China. JAMA Oncol. 2020;e200980. doi:10.1001/jamaoncol.2020.0980.
  • Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020: S0923-7534(20)36383-3. doi:10.1016/j.annonc.2020.03.296.
  • World Health Organization (WHO). Clinical Management of Severe Acute Respiratory Infection when novel coronavirus (nCoV) infection is suspected. Interim Guidance. Geneva: World Health Organization; 2020.
  • Sama IE, Ravera A, Santema BT, et al. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J. 2020;41(19):1810–1817. doi:10.1093/eurheartj/ehaa373.32388565
  • Luo J, Rizvi EJV, Preeshagul IR, Wolchok JD, Hellmann MD. Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers. Cancer Discov. 2020:CD-20-0596. doi:10.1158/2159-8290.CD-20-0596.
  • Garassino MC, Whisenant JG, Huang L-C, et al. COVID-19 in patients with thoracic malignancies (TERAVOLT) first results of an international, registry-based, cohort study. Lancet Oncol. 2020;21:914–922. doi:10.1016/S1470-2045(20)30314-4.32539942
  • El-Arabey AA, Abdalla M. Transplacental transmission of SARS-CoV-2 infection via NRP1. Travel Med Infect Dis. 2021;40:101987. doi:10.1016/j.tmaid.2021.101987.33561526
  • Hong T-M, Chen Y-L, Wu -Y-Y, et al. Targeting neuropilin 1 as an antitumor strategy in lung cancer. Clin Cancer Res. 2007;13:4759–4768. doi:10.1158/1078-0432.CCR-07-0001.17699853
  • Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020. doi:10.1001/jama.2020.4683.
  • Dai M, Liu D, Liu M, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a Multi-Center Study during the COVID-19 outbreak. Cancer Discov. 2020:CD-20-0422. doi:10.1158/2159-8290.CD-20-0422.
  • Zheng C, Wang J, Guo H, et al. Risk-adapted treatment strategy for COVID-19 patients. Int J Infect Dis. 2020;94:74–77. doi:10.1016/j.ijid.2020.03.047.32229257
  • Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7.32007143
  • Provencio M, Carcereny E, Rodríguez-Abreu D, et al. Lung cancer in Spain: information from the Thoracic Tumors Registry (TTR Study). Trans Lung Cancer Res. 2019;8(4):461–475. doi:10.21037/tlcr.2019.08.05.
  • Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):e201127. doi:10.1001/jamaneurol.2020.1127.
  • Paz-Ares L, Luft A, Vicente D, et al. Pembrolizumab plus chemotherapy for squamous non–small-cell lung cancer. N Engl J Med. 2018;379:2040–2051. doi:10.1056/NEJMoa1810865.30280635